George Buchman

Vice President, Preclinical Service and Process Development • Catalent Cell and Gene Therapy

Dr. Buchman joined Catalent through its acquisition of Paragon Gene Therapy in 2019. He has more than 30 years of experience in the biotech industry, and has held roles at companies including Life Technologies (now Thermo Fisher), Celera Genomics and Gene Logic. Dr. Buchman obtained a bachelor’s degree in biochemistry from Albright College, Reading, Pennsylvania, and a doctorate in biochemistry from University of Maryland.

Also Speaking

Mark Throsby

Chief Scientific Officer • Gadeta

Sander Van Deventer

Chief Scientific Officer • Porton Advanced

David Fontana

Chief Business and Strategy Officer • Umoja Biopharma

Event Info


Fun Run